KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Evolent Health (EVH) Depreciation & Amortization (IS) (2016 - 2025)

Evolent Health (EVH) has 11 years of Depreciation & Amortization (IS) data on record, last reported at $45.0 million in Q4 2025.

  • For Q4 2025, Depreciation & Amortization (IS) rose 53.73% year-over-year to $45.0 million; the TTM value through Dec 2025 reached $115.9 million, down 2.13%, while the annual FY2025 figure was $115.9 million, 2.13% down from the prior year.
  • Depreciation & Amortization (IS) reached $45.0 million in Q4 2025 per EVH's latest filing, up from $23.6 million in the prior quarter.
  • Across five years, Depreciation & Amortization (IS) topped out at $45.0 million in Q4 2025 and bottomed at $14.9 million in Q3 2021.
  • Average Depreciation & Amortization (IS) over 5 years is $24.7 million, with a median of $24.1 million recorded in 2025.
  • Peak YoY movement for Depreciation & Amortization (IS): soared 112.64% in 2023, then decreased 22.53% in 2025.
  • A 5-year view of Depreciation & Amortization (IS) shows it stood at $15.1 million in 2021, then surged by 31.22% to $19.8 million in 2022, then soared by 49.65% to $29.6 million in 2023, then dropped by 1.03% to $29.3 million in 2024, then surged by 53.73% to $45.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation & Amortization (IS) were $45.0 million in Q4 2025, $23.6 million in Q3 2025, and $23.1 million in Q2 2025.